Denials rarely start with a coding error. They start weeks earlier, at the point of care, when a wound gets described instead of measured. A note that says “improving, continue current dressing” gives a payer nothing to verify and gives a TPE reviewer every reason to ask for more. The seven strategies below fix the documentation habits that create audit exposure and revenue leakage, and they build on each other: structured assessment feeds debridement justification, debridement data feeds CTP eligibility, and automated supply ordering keeps the treatment plan and the DME order in sync. None of this requires new clinical judgment. It requires charting what you already know in a form the payer, the auditor, and your own dashboard can use.
1. Standardize wound assessment with structured, TIMERS-based documentation
Free-text wound notes are among the most common sources of unnecessary additional documentation requests. A note that reads “wound looks better” carries no tissue percentages, no measurement trend, and no periwound detail, so when a payer asks for support, there’s nothing to send. Structured, TIMERS-based fields (tissue, infection/inflammation, moisture, edge, repair/regeneration, social factors) force every encounter to produce comparable, measurable data regardless of which provider is charting.
Consider a mobile wound practice rounding across multiple SNFs with a rotating roster of NPs and PAs. When assessment fields are standardized in the EHR, the same wound charted by three different providers over three weeks still produces a consistent measurement trend. That consistency is what closes the narrative gaps that trigger additional documentation requests in the first place, and it’s the foundation for chronic wound outcomes data your practice can actually use for benchmarking.
- Build assessment templates with required structured fields: measurements, tissue-type percentages, exudate volume and type, periwound condition.
- Lock the fields so they cannot be skipped or bypassed with a single free-text line.
- Train providers to complete the template at the bedside, not from memory after rounds.
- Audit a sample of charts monthly for field completeness, not just note length.
The common failure mode is letting a free-text override field become the default entry method. Once providers discover they can type a paragraph instead of filling six required fields, the template stops producing structured wound care data and you’re back to narrative notes with better formatting. Track the percentage of encounters with fully completed structured fields versus free-text-only entries every month, and treat a rising free-text rate as a training gap, not a minor workflow quirk.
2. Tie debridement method to documented wound bed preparation stage
Debridement claims get denied or clawed back most often not because the wrong procedure was performed, but because the chart doesn’t show why it was still necessary. Before anything else, know which debridement is separately billable and which isn’t. Selective and sharp debridement are reported with 97597/97598 or, by depth of tissue removed, with 11042–11047. Non-selective debridement, including enzymatic, is reported with 97602, which carries a status B indicator on the Medicare Physician Fee Schedule and is bundled into payment for other services. Autolytic debridement isn’t separately reportable at all, though it still belongs in the note, because the dressings supplied to accomplish it depend on it being documented.
That distinction matters for a second reason: CPT code selection is driven by the depth of tissue actually removed and the surface area debrided, not by the percentage of necrotic tissue in the bed. Tissue-type percentages don’t pick the code. They establish medical necessity and show the wound’s response over time, which is precisely what debridement audit documentation requirements ask for.
A hospital-based outpatient wound center that charts declining necrotic tissue percentage across consecutive visits, say from 60% to 35% to 15%, has a documented basis for continued sharp debridement billing. A center that repeats “wound debrided” without measurements, without naming the instrument used, and without describing the character of the wound before and after has nothing to show a reviewer asking why the same code was billed six times in a row.
Require a tissue-type breakdown (percent necrotic, slough, granulation) and a depth/area measurement at every debridement encounter, and make sure the note independently documents the level of tissue removed and the method used. The mistake to avoid is defaulting to the same method visit after visit without re-justifying it against current tissue status. As registry data on debridement billing patterns has shown, charts that bill subcutaneous debridement week after week on wounds that are already 76 to 100% granulated probably won’t survive an audit. A wound that’s been sharp-debrided for eight weeks with no measurable shift toward granulation isn’t just a stalled wound, it’s a stalled-wound audit flag waiting to be pulled. Track weeks to transition from necrotic/slough-dominant to granulation-dominant tissue after debridement initiation, and use that figure to catch method mismatches before an auditor does.
3. Require objective arterial assessment before ordering compression
Compression therapy for venous leg ulcers carries real risk when arterial disease is undiagnosed, and payers know it. An arterial assessment documented before the compression order isn’t just a safety check, it’s the medical necessity evidence a claim needs to survive review. Ordering compression on clinical impression alone is one of the more preventable reasons a compression claim gets denied, and a far more preventable reason to compress an ischemic limb.
One caution on method. An ABI is generally adequate to decide whether compression can be applied safely, but it is not adequate to establish whether a wound will heal, and calcified vessels can produce falsely normal values. That’s why many practitioners performing the CMS-endorsed US Wound Registry arterial assessment quality measure use toe pressures, transcutaneous oximetry, or skin perfusion pressure rather than an ABI alone. Build the field to accept whichever method was performed, and require a value, not a checkbox.
- Add an arterial assessment result field as a hard prerequisite in the compression order screen; the order shouldn’t generate without a documented value and method.
- Build in a reassessment prompt every 4 to 6 weeks or whenever edema changes significantly.
- Reassess fit and method, not just arterial status, since limb circumference shifts with therapy.
The mistake practices make is ordering compression once at the initial visit and letting that order run indefinitely. As edema resolves, wrap size and compression class often need adjustment, and adequate compression is harder to sustain than most programs assume: published registry work found that only 17% of venous leg ulcers left a hospital-based outpatient clinic in adequate compression. Measure the percentage of active compression orders with an arterial assessment documented within the prior 90 days, and treat any gap as an open denial risk, not a paperwork backlog.
4. Document offloading adherence at every DFU visit
Total contact casting remains the reference standard for plantar diabetic foot ulcers, and when a removable device is chosen instead, the chart needs to say why, every visit, not just at the start of care. The gap most charts have isn’t the offloading device choice itself, it’s the assumption that the patient is wearing it as directed. Assumed adherence is not documented adherence, and a wound that fails to progress with no charted adherence check looks like a treatment failure rather than a compliance issue.
The scale of the gap is well documented. In US Wound Registry data covering more than 221,000 visits, offloading of any kind was documented in only 2.2% of DFU visits, and among clinics that owned TCC capability, the overwhelming majority of TCC-eligible ulcers still didn’t receive one. A DPM-led mobile practice that adds a simple structured field, “worn as directed since last visit: yes/no,” at every DFU encounter catches non-adherence early enough to intervene, rather than discovering it eight weeks in when the wound hasn’t moved.
- Add a required adherence field to the DFU visit template.
- When TCC is not the chosen method, require a structured rationale field explaining why (patient factors, infection status, prior tolerance issues).
- Review adherence trends at each visit alongside percent area reduction, not as a separate afterthought.
Treating removable offloading as the unspoken default, without documenting why TCC was ruled out, weakens the medical necessity record if the wound stalls and a payer or auditor asks why a higher standard of care wasn’t used. Track percent area reduction at 4 weeks for offloaded DFUs, segmented by TCC versus removable device, against published DFU healing rate benchmarks. If your removable-device cohort consistently underperforms, that’s a signal to revisit the rationale threshold, not just the adherence question.
5. Apply CTP/skin substitutes only after documented conservative-care failure
CTP claims draw more scrutiny than almost any other line item in a wound program’s billing, and the coverage landscape shifted underneath everyone at the end of 2025. On December 24, 2025, the MACs withdrew the harmonized skin substitute LCDs that had been scheduled to take effect January 1, 2026. Only three MACs, Novitas, CGS, and First Coast, currently maintain active CTP LCDs, and auditors routinely use those three policies as benchmarks nationwide, even when the audited provider practices outside the issuing MAC’s jurisdiction.
Read that carefully, because the practical implication runs opposite to what most people assume. The absence of an LCD in your jurisdiction is not the absence of a documentation standard. Meanwhile, the payment side did not get withdrawn: under the CY 2026 Physician Fee Schedule, CTPs are paid as incident-to supplies at a flat rate of roughly $127 per square centimeter, effective January 1, 2026. Audits continue, margins are thinner, and the documentation bar is set by the three active policies plus the statutory reasonable-and-necessary standard. Every one of those active policies requires a documented period of standard care, generally at least four weeks, with failure to heal, before a CTP goes on.
A wound center that logs percent area reduction across the full conservative-care window before applying a CTP produces exactly the data point a reviewer asks for first: a measurable trend showing standard therapy wasn’t enough. That same tracking, aggregated across patients, also becomes a control arm for matched cohort wound care studies your practice might later participate in, since it establishes a real-world baseline.
Build a conservative-care tracking field that calculates percent area reduction automatically from serial measurements, and flag the wound as CTP-eligible only once the documented threshold and timeframe are actually met. The most common and most avoidable mistake is applying a CTP on clinical judgment alone, without a charted percent-area-reduction trend from the preceding weeks. Track the percentage of CTP claims with a fully documented conservative-care trend attached at time of billing, and treat anything under 100% as an open compliance risk. This same structured data, aggregated over time, is also what supports internal analysis of skin sub comparative efficacy and wound size at first CTP application across your own patient population, rather than relying solely on manufacturer claims.
6. Automate chart-to-door supply ordering
The lag between what’s charted in the treatment plan and what actually arrives at the patient’s bedside or home is a quiet but persistent driver of reorder lapses, wound deterioration, and wasted follow-up visits. When dressing orders are a manual, end-of-week batch task handled by office staff, the order date can trail the visit date by several days, and the supply that arrives may not even match what was charted if the note was updated after the initial order was pulled.
There’s an audit dimension here that gets overlooked. The dressing supplied has to match what the chart says about the wound. If the nurse records drainage as minimal because the patient changed a saturated dressing on the way to clinic, and the DME sends an alginate plus an absorbent secondary dressing, those dressings will be considered improperly paid on audit. The same happens when autolytic or enzymatic debridement is being performed but the note says no debridement occurred. Structured exudate documentation is what keeps the supply and the chart defensible; drainage volume distribution data on venous leg ulcers shows how directly exudate level drives which dressing categories are appropriate in the first place.
A mobile wound practice that ties dressing orders directly to the treatment plan section of the note eliminates that gap. Selecting the dressing type and frequency in the note transmits the order to the supplier the same day, rather than sitting in an inbox until Friday.
To put this into practice: configure automated supply ordering rules within the EHR workflow so that documenting a dressing type and change frequency in the note generates the physician DME order automatically, with no separate manual entry step for staff to remember or delay. This also keeps the order history and the chart in permanent agreement, which matters if a payer ever questions whether the supply billed matches the supply charted.
The common mistake is leaving supply ordering as an end-of-day or end-of-week manual task. Every day that gap persists is a day the patient may be reusing a saturated dressing or going without, which shows up later as a wound that didn’t progress on schedule for reasons that have nothing to do with the treatment plan itself. Measure average days from order generation to patient delivery, and track reorder lapse rate between visits, meaning how often a patient runs out of supply before the next scheduled order.
7. What Are the Best Chronic Wound Management Strategies for Escalating Stalled Wounds?
A wound that isn’t progressing on a predictable trajectory and keeps getting the same treatment plan for months is one of the clearest markers a reviewer looks for. Percent area reduction over the first four weeks is a well-established predictor of eventual healing, but the threshold is wound-type specific and the commonly cited figures are higher than many programs assume. For diabetic foot ulcers, Sheehan’s 2003 prospective analysis put the midpoint between healers and non-healers at roughly 53% area reduction at four weeks, and a 50% cutoff has been validated in subsequent cohorts. For venous leg ulcers, failure to achieve about 40% reduction at four weeks has been reported as the strongest negative predictor of nonhealing. Those two numbers are not interchangeable, so confirm which applies to which wound type before setting a single internal cutoff.
It’s also worth knowing that a four-week trajectory isn’t the only way to identify a wound that won’t heal. The Wound Healing Index, developed from US Wound Registry data and accepted by CMS for outcome reporting under the Quality Payment Program, makes it possible to predict at the initial visit whether a venous leg ulcer will heal with standard care, using wound and patient factors rather than waiting four weeks to find out.
Whatever threshold your medical director adopts, the operational fix is the same: track percent area reduction against that healing-trajectory benchmark, and trigger a documented escalation decision, advanced dressing, CTP, surgical referral, or vascular workup, whenever a wound misses it. A wound center dashboard that flags any wound falling short of the four-week threshold for medical director review turns a passive “continue current plan” default into an active decision point with a paper trail.
- Set up automated healing-trajectory tracking pulled from serial wound measurements already in the chart.
- Configure an alert to the treating provider and medical director when a wound crosses the stall threshold.
- Require a documented next-step decision, not just an acknowledgment, before the next visit.
- Log the decision and rationale in the chart so it’s visible on review.
The mistake that recurs across wound programs, regardless of setting, is continuing an unchanged treatment plan for months without ever charting an escalation decision. To a reviewer, that pattern reads as either inattention or an attempt to keep billing a lower-intensity code rather than moving to appropriate advanced therapy. Measure the number of wounds flagged as stalled that receive a documented escalation decision within one week of the flag, and treat a low rate as a workflow failure rather than a clinical one.
Sequencing These Strategies for Maximum Audit Protection
Start with structured TIMERS-based assessment and automated chart-to-door supply ordering. Every other strategy on this list depends on one or the other. Debridement justification, arterial-gated compression orders, offloading adherence tracking, and CTP eligibility all pull their data from the same structured assessment fields, so if that foundation is still free-text, the strategies built on top of it inherit the same documentation gaps. Automated supply ordering, meanwhile, closes the loop on the other end, making sure what’s charted and what’s delivered never drift apart, which matters whenever a payer cross-references billed supplies against the treatment plan.
Once those two are running cleanly, the debridement, compression, offloading, and CTP strategies layer on with minimal additional workflow change, since they’re really just extensions of the same structured data already being captured. The stalled-wound escalation strategy is the natural last step, because it depends on having a clean measurement trend to detect a stall against in the first place.
A wound care EHR built specifically for this workflow, rather than adapted from a general medical record, makes this sequencing far easier to execute and sustain across a mobile practice, a hospital-based center, or a SNF-facing wound team. Click here to learn more.
